Search results
How Crackers Went From Survival Food to Gourmet Treat
The Wall Street Journal· 19 hours agoInvented to feed soldiers and sailors on the move, crackers are now showing up on high-end...
To spur a rural rebound, one Minnesota county is paying college athletes to promote it
USA TODAY via Yahoo News· 50 minutes agoA drop like that would be devastating for a community that already had trouble filling key positions at its medical facilities and manufacturing companies, from smaller machine and auto repair ...
Could Investing $15,000 in Axcelis Technologies Make You a Millionaire?
Motley Fool via Yahoo Finance· 1 day agoPolaroid cameras, dial-up modems, and encyclopedias come to mind. Landline phones and newspapers are...
Are Ultra-Processed Foods Really all that Unhealthy?
Scientific American· 23 hours agoThe problem, according to this increasingly popular argument, is that we’re eating lots of ultra-processed food or UPF. Traditionally, people used...
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 20 hours agoGilead Sciences also reported a market capitalisation decline, of 9.6%, in Q1 2024, primarily due to...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 3 days agoThe company also recently said its new drug Adcetris — courtesy of its $43 billion takeover of...
Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in...
Morningstar· 2 days agoFood and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CTX-009, the Company’s bispecific DLL4/VEGF-A antibody, in combination with ...
Is Fallout a warning for our future? A global catastrophe risk expert weighs in.
Vox· 24 hours agoFallout takes place in two different periods in the Los Angeles area: the moments before nuclear...
ImmunityBio immunotherapy shows positive overall survival in lung cancer trial (NASDAQ:IBRX)
Seeking Alpha· 2 days agoImmunityBio's immunotherapy drug, Anktiva, shows positive results in a trial for non-small cell lung cancer, boosting shares by 17% premarket.
The Wrong Question to Ask About Climate Change
The New Republic via Yahoo News· 1 day agoThree offshore wind projects in New York have been canceled, one of a string of developments complicating the state’s progress toward 70 percent...